Osteopontin in the development of systemic sclerosis-relation to disease activity and organ manifestation

Rheumatology

Volumn 49, Issue 10, 2010, Pages 1989-1991

  Lorenzen, Johan M ^a   Krämer, Robert ^a   Meier, Matthias ^a   Werfel, Thomas ^a   Wichmann, Katja ^a   Hoeper, Marius M ^a   Riemekasten, Gabriela ^b   Becker, Mike O ^b   Haller, Hermann ^a   Witte, Torsten ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CENTROMERE ANTIBODY; INTERLEUKIN 1BETA; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL MIGRATION; CELL PROLIFERATION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS DISEASE; FIBROSING ALVEOLITIS; GERMANY; HUMAN; INFORMED CONSENT; LETTER; LUNG FIBROSIS; ORGAN INJURY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SKIN CALCIFICATION; SKIN MANIFESTATION; SYSTEMIC SCLEROSIS;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; HUMANS; OSTEOPONTIN; PREDICTIVE VALUE OF TESTS; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC;

EID: 77956845939     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq223     Document Type: Letter

References (8)

1. Black CM. The aetiopathogenesis of systemic sclerosis: thick skin-thin hypotheses. The Parkes Weber Lecture 1994. J R Coll Physicians Lond 1995;29:119.
2. Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy. Lancet 1996;347: 1453.
3. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J. Osteopontin-a molecule for all seasons. Q J Med 2002;95:3-13.
4. Collins AR, Schnee J, Wang W et al. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J Am Coll Cardiol 2004;43:1698-705.
5. Wolak T, Kim H, Ren Y, Kim J, Vaziri ND, Nicholas SB. Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int 2009;76:32-43.
6. Pardo A, Gibson K, Cisneros J et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005;2:e251.
7. Mori R, Shaw TJ, Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 2008;205:43-51.
8. Fan K, Dai J, Wang H et al. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. Arthritis Rheum 2008;58:2041-52.